Optimind Pharma Corp. announced a private placement to issue 10,000,000 common shares at a price of CAD 0.05 per share for gross proceeds of up to CAD 500,000 on July 3, 2024. All securities issued in connection with the private placement will be subject to a statutory hold period expiring four months and one day from the date of issuance of the securities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% |
|
0.00% | 0.00% |
Jul. 03 | Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding | CI |
Jun. 29 | Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 29, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 428K | |
+19.44% | 125B | |
+20.01% | 114B | |
+23.09% | 26.73B | |
-23.72% | 19.43B | |
-17.66% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |
- Stock Market
- Equities
- OMND Stock
- News Optimind Pharma Corp.
- Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding